Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S. (Amsterdam UMC)
Bijlenga, D. (Amsterdam UMC)
Salerno, L. (Institute of Neuroscience (Florència))
Jaeschke, R. (Jagiellonian University Medical College (Polònia))
Bitter, I. (DPC Naestved)
Balázs, J. (Vadaskert Child Psychiatric Hospital)
Thome, J. (St. George Hospital (Líban))
Dom, Geert (Istanbul Institute pf Child amd Adolescent Psychiatry)
Kasper, S. (Medical University of Viena)
Nunes Filipe, C. (Universidade NOVA Lisboa)
Stes, S. (University Psychiatric Center (Bélgica))
Mohr, Pavel (Charles University Prague)
Leppämäki, S. (Helsinki University Central Hospital)
Casas Brugué, Miquel
Bobes, Julio (Parenting and Special Education (Bélgica))
Mccarthy, J. M. (King's College London)
Richarte, Vanesa (Hospital Universitari Vall d'Hebron)
Kjems Philipsen, A. (NPC Naestved (Dinamarca))
Pehlivanidis, A. (National and Kapodistrian University of Athens Medical School)
Niemela, A. (Wellming Terveys Oy (Finlandia))
Styr, B. (Jagiellonian University Medical College (Polònia))
Semerci, B. (Hasan Kalyoncu University)
Bolea-Alamanac, B. (University of Toronto)
Edvinsson, Dan (Upsala University)
Baeyens, D. (Parenting and Special Education (Bélgica))
Wynchank, D. (Amsterdam UMC)
Sobanski, E. (University Medical Center Mainz)
Philipsen, A. (University of Bonn)
Caci, Herve (Hospitaux Pediatriques de Nice CHU Lenval)
Mihailescu, I. (Alexandru Obregia Clinical Hospital of Psychiatria Bucharest)
Manor, I. (Geha MHC (Israel))
Dobrescu, I. (Jagiellonian University Medical College (Polònia))
Krause, J. (Outpatient Clinic (Alemanya))
Fayyad, John (St. George University Medical Center (Líban))
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Foeken, K. (Vieux Chemin de Cagnes à La Gaude (França))
Rad, F. (University of Medicine and Pharmacy "Carol Davila")
Adamou, M. (University of Huddersfield)
Ohlmeier, M. (Klinicum Kassel)
Fitzgerald, M. (Charles University Prague)
Gill, M. (Trinity College Dublin)
Lensing, M. (Antwerp University)
Motavalli Mukaddes, N. (Centrum Drobej Terapii (Polònia))
Brudkiewicz, P. (Lund University)
Gustafsson, P. (Karolinska Institutet (Estocolm, Suècia))
Tani, P. (High Security Hospital (Bélgica))
Carpentier, Pieter Jan (Reinier van Arkel Mental Health Institute)
De Rossi, P. (Sapienza Univerity of Rome)
Delorme, R. (Robert Debré Hospital)
Markovska Simoska, S. (Macedonian Academy of Sciences and Arts)
Pallanti, S. (Standford University Medical Center)
Young, S. (Psychology Services Limited (Regne Unit))
Bejerot, Susanne (Örebro University)
Lehtonen, T. (Neuropsykologkonsult Taina Lethonen (Suècia))
Kustow, J. (Barnet Hospital)
Müller-Sedgwick, U. (University of Cambridge)
Hirvikoski, T. (Karolinska Institutet (Estocolm, Suècia))
Pironti, V. (Cambridge Adult ADHD & ASD Clinic)
Ginsberg, Y. (Karolinska Institutet (Estocolm, Suècia))
Félegeházy, Z. (Jagiellonian University Medical College (Polònia))
García-Portilla, Maria-Paz (Universidad de Oviedo)
Asherson, Philip (King's College London)
Universitat Autònoma de Barcelona

Data:	2019
Resum:	Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	European psychiatry, Vol. 56 (february 2019) , p. 14-34, ISSN 1778-3585

DOI: 10.1016/j.eurpsy.2018.11.001

21 p, 1.1 MB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats